[1]
O. T. Seren, “Dupilumab after sequential omalizumab and benralizumab failure in T2-high asthma–COPD overlap: A case report”, Allergol Immunopathol, vol. 54, no. 3, pp. 180–183, May 2026, doi: 10.15586/aei.v54i3.1566.